<SEC-DOCUMENT>0001564590-21-027565.txt : 20210513
<SEC-HEADER>0001564590-21-027565.hdr.sgml : 20210513
<ACCEPTANCE-DATETIME>20210513161745
ACCESSION NUMBER:		0001564590-21-027565
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		14
CONFORMED PERIOD OF REPORT:	20210513
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20210513
DATE AS OF CHANGE:		20210513

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Terns Pharmaceuticals, Inc.
		CENTRAL INDEX KEY:			0001831363
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39926
		FILM NUMBER:		21919882

	BUSINESS ADDRESS:	
		STREET 1:		1065 EAST HILLSDALE BLVD., SUITE 100
		CITY:			FOSTER CITY
		STATE:			CA
		ZIP:			94404
		BUSINESS PHONE:		650-525-5535 EXT.101

	MAIL ADDRESS:	
		STREET 1:		1065 EAST HILLSDALE BLVD., SUITE 100
		CITY:			FOSTER CITY
		STATE:			CA
		ZIP:			94404
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>tern-8k_20210513.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml  version="1.0" encoding="utf-8"?>
<!-- DFIN ActiveDisclosure(SM) Inline XBRL Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date      : 2021-05-13T05:27:47.2958048+00:00 -->
<!-- Version            : 5.0.1.615 -->
<!-- Package ID         : 16ad461f404a4152b2b59769edde4f81 -->
<!-- Copyright (c) 2021 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<html xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:tern="http://www.ternspharma.com/20210513" xmlns:us-types="http://fasb.org/us-types/2020-01-31" xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31" xmlns:stpr="http://xbrl.sec.gov/stpr/2018-01-31" xmlns:srt-types="http://fasb.org/srt-types/2020-01-31" xmlns:srt="http://fasb.org/srt/2020-01-31" xmlns:sic="http://xbrl.sec.gov/sic/2020-01-31" xmlns:naics="http://xbrl.sec.gov/naics/2017-01-31" xmlns:exch="http://xbrl.sec.gov/exch/2020-01-31" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:dei-std="http://xbrl.sec.gov/dei-std/2020-01-31" xmlns:dei-ent-std="http://xbrl.sec.gov/dei-ent-std/2020-01-31" xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31" xmlns:currency="http://xbrl.sec.gov/currency/2020-01-31" xmlns:country="http://xbrl.sec.gov/country/2020-01-31" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns="http://www.w3.org/1999/xhtml">
<head>
<meta http-equiv="Content-Type" content="text/html" />
<title>
tern-8k_20210513.htm
</title>
</head>
<!-- NG Converter v5.0.2.50 -->
<body><div style="display:none">
	<ix:header>
		<ix:hidden>
			<ix:nonNumeric id="F_000001" name="dei:AmendmentFlag" contextRef="C_0001831363_20210513_20210513">false</ix:nonNumeric>
			<ix:nonNumeric id="F_000004" name="dei:EntityCentralIndexKey" contextRef="C_0001831363_20210513_20210513">0001831363</ix:nonNumeric>
		</ix:hidden>
		<ix:references>
			<link:schemaRef xlink:type="simple" xlink:href="tern-20210513.xsd" xlink:arcrole="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase"></link:schemaRef>
		</ix:references>
		<ix:resources>
			<xbrli:context id="C_0001831363_20210513_20210513">
				<xbrli:entity>
					<xbrli:identifier scheme="http://www.sec.gov/CIK">0001831363</xbrli:identifier>
				</xbrli:entity>
				<xbrli:period>
					<xbrli:startDate>2021-05-13</xbrli:startDate>
					<xbrli:endDate>2021-05-13</xbrli:endDate>
				</xbrli:period>
			</xbrli:context>
		</ix:resources>
	</ix:header>
</div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;border-top:Solid 0.75pt #000000;padding-top:1pt;text-indent:0%;font-size:4pt;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:18pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">UNITED STATES </p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:18pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">SECURITIES AND EXCHANGE COMMISSION </p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Washington, D.C. 20549 </p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;border-bottom:Solid 1pt #000000;padding-bottom:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:18pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">FORM <ix:nonNumeric id="F_000000" name="dei:DocumentType" contextRef="C_0001831363_20210513_20210513">8-K</ix:nonNumeric> </p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;border-bottom:Solid 1pt #000000;padding-bottom:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">CURRENT REPORT </p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Pursuant to Section&#160;13 or 15(d) of the </p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Securities Exchange Act of 1934 </p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Date of Report (Date of earliest event reported): <ix:nonNumeric id="F_000002" name="dei:DocumentPeriodEndDate" contextRef="C_0001831363_20210513_20210513" format="ixt:datemonthdayyearen">May 13, 2021</ix:nonNumeric> </p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;border-bottom:Solid 1pt #000000;padding-bottom:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:24pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000003" name="dei:EntityRegistrantName" contextRef="C_0001831363_20210513_20210513">Terns Pharmaceuticals, Inc.</ix:nonNumeric> </p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(Exact name of registrant as specified in its charter) </p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;border-bottom:Solid 1pt #000000;padding-bottom:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="middle" style="width:34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:8pt;">&#160;</p></td>
<td valign="bottom" style="width:auto;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:8pt;">&#160;</p></td>
<td valign="middle" style="width:32%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:8pt;">&#160;</p></td>
<td valign="bottom" style="width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:8pt;">&#160;</p></td>
<td valign="middle" style="width:32%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:8pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="width:auto;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000008" name="dei:EntityIncorporationStateCountryCode" contextRef="C_0001831363_20210513_20210513" format="ixt-sec:stateprovnameen">Delaware</ix:nonNumeric></p></td>
<td valign="bottom" style="width:auto;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="width:auto;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000007" name="dei:EntityFileNumber" contextRef="C_0001831363_20210513_20210513">001-39926</ix:nonNumeric></p></td>
<td valign="bottom" style="width:auto;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="width:auto;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000009" name="dei:EntityTaxIdentificationNumber" contextRef="C_0001831363_20210513_20210513">98-1448275</ix:nonNumeric></p></td>
</tr>
<tr>
<td valign="top" style="width:auto;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(State or other jurisdiction</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">of incorporation)</p></td>
<td valign="bottom" style="width:auto;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="width:auto;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(Commission</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">File Number)</p></td>
<td valign="bottom" style="width:auto;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="width:auto;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(IRS Employer</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Identification Number)</p></td>
</tr>
</table></div>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000010" name="dei:EntityAddressAddressLine1" contextRef="C_0001831363_20210513_20210513">1065 East Hillsdale Blvd</ix:nonNumeric>., <ix:nonNumeric id="F_000011" name="dei:EntityAddressAddressLine2" contextRef="C_0001831363_20210513_20210513">Suite 100</ix:nonNumeric></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000012" name="dei:EntityAddressCityOrTown" contextRef="C_0001831363_20210513_20210513">Foster City</ix:nonNumeric>, <ix:nonNumeric id="F_000013" name="dei:EntityAddressStateOrProvince" contextRef="C_0001831363_20210513_20210513" format="ixt-sec:stateprovnameen">California</ix:nonNumeric> <ix:nonNumeric id="F_000014" name="dei:EntityAddressPostalZipCode" contextRef="C_0001831363_20210513_20210513">94404</ix:nonNumeric> <br /><span style="font-size:8pt;">(Address of principal executive offices, including Zip Code) </span></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Registrant&#8217;s telephone number, including area code: (<ix:nonNumeric id="F_000015" name="dei:CityAreaCode" contextRef="C_0001831363_20210513_20210513">650</ix:nonNumeric>) <ix:nonNumeric id="F_000016" name="dei:LocalPhoneNumber" contextRef="C_0001831363_20210513_20210513">525-5535</ix:nonNumeric></p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;border-bottom:Solid 1pt #000000;padding-bottom:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: &#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:3.33%;text-indent:0%;font-size:10pt;font-family:Segoe UI Symbol;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000017" name="dei:WrittenCommunications" contextRef="C_0001831363_20210513_20210513" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric> <span style="font-family:Times New Roman;">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) </span></p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:3.33%;text-indent:0%;font-size:10pt;font-family:Segoe UI Symbol;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000018" name="dei:SolicitingMaterial" contextRef="C_0001831363_20210513_20210513" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric> <span style="font-family:Times New Roman;">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) </span></p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:3.33%;text-indent:0%;font-size:10pt;font-family:Segoe UI Symbol;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000019" name="dei:PreCommencementTenderOffer" contextRef="C_0001831363_20210513_20210513" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric> <span style="font-family:Times New Roman;">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) </span></p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:3.33%;text-indent:0%;font-size:10pt;font-family:Segoe UI Symbol;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000020" name="dei:PreCommencementIssuerTenderOffer" contextRef="C_0001831363_20210513_20210513" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric> <span style="font-family:Times New Roman;">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) </span></p>
<p style="margin-bottom:0pt;margin-top:0pt;border-bottom:Solid 0.75pt #000000;padding-bottom:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Securities registered pursuant to Section&#160;12(b) of the Act:</p>
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:12pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="middle" style="background-color:#FFFFFF;width:34%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;width:auto;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="middle" style="background-color:#FFFFFF;width:32%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;width:1%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="middle" style="background-color:#FFFFFF;width:32%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="background-color:#FFFFFF;width:auto; border-bottom:solid 1pt #000000;white-space:nowrap;">
<p style="text-align:center;margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Title of each class</p></td>
<td valign="bottom" style="background-color:#FFFFFF;width:auto; border-bottom:solid 1pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;width:auto; border-bottom:solid 1pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Trading</p>
<p style="text-align:center;margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Symbol(s)</p></td>
<td valign="bottom" style="background-color:#FFFFFF;width:auto; border-bottom:solid 1pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:8pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="bottom" style="background-color:#FFFFFF;width:auto; border-bottom:solid 1pt #000000;">
<p style="text-align:center;margin-bottom:1pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:8pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Name of each exchange on which registered</p></td>
</tr>
<tr>
<td valign="top" style="background-color:#FFFFFF;width:auto;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000021" name="dei:Security12bTitle" contextRef="C_0001831363_20210513_20210513">Common Stock, $0.0001 par value per share</ix:nonNumeric></p></td>
<td valign="bottom" style="background-color:#FFFFFF;width:auto;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;width:auto;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000022" name="dei:TradingSymbol" contextRef="C_0001831363_20210513_20210513">TERN</ix:nonNumeric></p></td>
<td valign="bottom" style="background-color:#FFFFFF;width:auto;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></td>
<td valign="top" style="background-color:#FFFFFF;width:auto;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><ix:nonNumeric id="F_000023" name="dei:SecurityExchangeName" contextRef="C_0001831363_20210513_20210513" format="ixt-sec:exchnameen">The Nasdaq Global Select Market</ix:nonNumeric></p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</p>
<p style="margin-bottom:0pt;margin-top:12pt;margin-right:4.07%;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Emerging growth company <span style="font-family:Segoe UI Symbol;"><ix:nonNumeric id="F_000005" name="dei:EntityEmergingGrowthCompany" contextRef="C_0001831363_20210513_20210513" format="ixt-sec:boolballotbox">&#9746;</ix:nonNumeric></span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. <span style="font-family:Segoe UI Symbol;"><ix:nonNumeric id="F_000006" name="dei:EntityExTransitionPeriod" contextRef="C_0001831363_20210513_20210513" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></span></p>
<p style="margin-bottom:0pt;margin-top:0pt;border-bottom:Solid 0.75pt;padding-bottom:1pt;text-indent:0%;font-size:4pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Item&#160;2.02 <span style="margin-left:36pt;"></span>Results of Operations and Financial Condition<span style="color:#000000;">.</span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On May 13, 2021, Terns Pharmaceuticals, Inc. issued a press release announcing its financial results for the three months ended March 31, 2021. A copy of the press release is attached as Exhibit 99.1 to this <span style="Background-color:#FFFFFF;">Current Report on&#160;Form&#160;8-K</span>.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="Background-color:#FFFFFF;">The information contained in Item 2.02 of this Current Report on&#160;Form&#160;8-K,&#160;including&#160;Exhibit 99.1 attached hereto, is being furnished and shall not be deemed &#8220;filed&#8221; for purposes of Section&#160;18 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), and shall not be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing</span>.</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Item&#160;9.01<span style="margin-left:36pt;"></span><span style="Background-color:#FFFFFF;">Financial Statements and Exhibits</span><span style="color:#000000;">.</span></p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(d) Exhibits</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:12pt;">&#160;</p>
<div style="align:left;">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="padding-Top:0pt;padding-Bottom:0pt;width:7.5%; border-bottom:solid 1pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exhibit</p>
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">No.</p></td>
<td valign="bottom" style="padding-Top:0pt;width:2.5%; border-bottom:solid 1pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="bottom" style="padding-Top:0pt;padding-Bottom:0pt;width:90%; border-bottom:solid 1pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Description</p></td>
</tr>
<tr>
<td valign="top" style="padding-Top:0pt;padding-Bottom:0pt;width:7.5%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="bottom" style="padding-Top:0pt;padding-Bottom:0pt;width:2.5%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-Top:0pt;padding-Bottom:0pt;width:90%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
</tr>
<tr>
<td valign="top" style="padding-Top:0pt;padding-Bottom:0pt;width:7.5%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">99.1</p></td>
<td valign="bottom" style="padding-Top:0pt;padding-Bottom:0pt;width:2.5%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-Top:0pt;padding-Bottom:0pt;width:90%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a href="tern-ex991_6.htm"><span style="text-decoration:underline;">Press Release issued by Terns Pharmaceuticals, Inc. on May 13, 2021.</span></a></p></td>
</tr>
<tr>
<td valign="top" style="padding-Top:0pt;padding-Bottom:0pt;width:7.5%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">104</p></td>
<td valign="bottom" style="padding-Top:0pt;padding-Bottom:0pt;width:2.5%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="top" style="padding-Top:0pt;padding-Bottom:0pt;width:90%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cover Page Interactive Data File (embedded within the Inline XBRL document)</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:5.15%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<hr style="page-break-after:always" />
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p>
<p style="text-align:center;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">SIGNATURES </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&#160;</p>
<div>
<table border="0" cellspacing="0" cellpadding="0" style="margin:auto;border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom" style="width:52.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td colspan="2" valign="bottom" style="width:47.86%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">TERNS PHARMACEUTICALS, INC.</p></td>
</tr>
<tr>
<td valign="bottom" style="width:52.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="bottom" style="width:2.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="bottom" style="width:45.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
</tr>
<tr>
<td valign="bottom" style="width:52.14%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Date: May 13, 2021</p></td>
<td valign="bottom" style="width:2.68%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">By:</p></td>
<td valign="bottom" style="width:45.18%; border-bottom:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">/s/ Bryan Yoon</p></td>
</tr>
<tr>
<td valign="bottom" style="width:52.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="bottom" style="width:2.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="bottom" style="width:45.18%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Bryan Yoon</p></td>
</tr>
<tr>
<td valign="bottom" style="width:52.14%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="bottom" style="width:2.68%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&#160;</p></td>
<td valign="bottom" style="width:45.18%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Chief Operating Officer &#38; General Counsel</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;">&#160;</p>
<p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&#160;</p></body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>tern-ex991_6.htm
<DESCRIPTION>EX-99.1
<TEXT>
<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
<head>
<title>
tern-ex991_6.htm
</title>
</head>
<!-- NG Converter v5.0.2.50 -->
<body>

<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Exhibit 99.1</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><img src="gmqzhpypc0jy000001.jpg" title="" alt="" style="width:213px;height:86px;"><font style="margin-left:36pt;"></font>&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;"><a name="_AEIOULastRenderedPageBreakAEIOU1"></a>&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Terns Reports First Quarter 2021 Financial Results and Provides Corporate Update</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-style:italic;font-size:11pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">-Top-line data from the Phase 2a LIFT study of TERN-101 expected in June 2021- </p>
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Hlk534627919"></a><a name="_Hlk534628000"></a>FOSTER CITY, Calif. May 13, 2021 &#8211;Terns Pharmaceuticals, Inc. (&#8220;Terns&#8221; or the &#8220;Company&#8221;) (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis (NASH) and other chronic liver diseases, today reported financial results for the first quarter ended March 31, 2021&#160;and provided a corporate update.</p>
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#8220;Our development team has continued to rapidly advance our NASH clinical programs, with top-line data for the Phase 2a LIFT study of FXR agonist TERN-101 in NASH now accelerated into June 2021. In the LIFT study, in addition to safety and tolerability, we are assessing multiple non-invasive endpoints, including MRI-PDFF (proton density fat fraction), a marker of steatosis, as well as ELF (enhanced liver fibrosis) and cT1 (MRI corrected T1) which are markers of fibrosis and/or inflammation linked to clinical outcomes and histological improvements in chronic liver diseases,&#8221; said Senthil Sundaram, CEO at Terns. &#8220;In March, we initiated our first clinical trial of TERN-501 and look forward to announcing top-line data in the second half of 2021 that we hope will provide clinical confirmation of its high metabolic stability and differentiated pharmacokinetic profile.&#8221;</p>
<p style="Background-color:#FFFFFF;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-weight:bold;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Recent Developments and Anticipated 2021 Milestones </p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">TERN-101: Liver-distributed farnesoid X receptor (FXR) agonist</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.42%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="top" style="width:3.42%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></font><font style="font-size:11pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;"></font><font style="font-size:11pt;color:#000000;">Completed patient enrollment in the Phase 2a LIFT study in NASH patients in January 2021</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.42%;white-space:nowrap">
<p style="text-align:left;margin-top:0pt;margin-bottom:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="top" style="width:3.42%;white-space:nowrap">
<p style="text-align:left;margin-top:0pt;margin-bottom:0pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></font><font style="font-size:11pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="text-align:left;margin-top:0pt;margin-bottom:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;"></font><font style="font-size:11pt;color:#000000;">Expecting top-line data from the Phase 2a LIFT study in June 2021</font></p></td></tr></table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">TERN-501: Thyroid hormone receptor-beta (THR-&#946;) agonist</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.42%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="top" style="width:3.42%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></font><font style="font-size:11pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;"></font><font style="font-size:11pt;color:#000000;">Initiated dosing in a first-in-human Phase 1 SAD/MAD clinical trial in March 2021</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.42%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="top" style="width:3.42%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></font><font style="font-size:11pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;"></font><font style="font-size:11pt;color:#000000;">Expecting top-line data from the ongoing Phase 1 trial in 2H21</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.42%;white-space:nowrap">
<p style="text-align:left;margin-top:0pt;margin-bottom:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="top" style="width:3.42%;white-space:nowrap">
<p style="text-align:left;margin-top:0pt;margin-bottom:0pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></font><font style="font-size:11pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="text-align:left;margin-top:0pt;margin-bottom:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;"></font><font style="font-size:11pt;color:#000000;">Composition of matter claims allowed by USPTO</font></p></td></tr></table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Hlk71796463"></a>TERN-201: Vascular adhesion protein-1 (VAP-1) inhibitor</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.42%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="top" style="width:3.42%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></font><font style="font-size:11pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;"></font><font style="font-size:11pt;color:#000000;">Expecting to initiate dosing in 12-week Phase 1b clinical trial in NASH patients in 1H21 with expected top-line data in 1H22</font></p></td></tr></table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><a name="_Hlk71796449"></a><a name="_Hlk71796424"></a>GLP1-R: Oral, small-molecule receptor agonist</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.42%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="top" style="width:3.42%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></font><font style="font-size:11pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;"></font><font style="font-size:11pt;color:#000000;">Expecting to nominate a final candidate in 2H21 for further development</font></p></td></tr></table></div>
<p style=" clear:both;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Strengthened balance sheet</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.57%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="top" style="width:3.57%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></font><font style="font-size:11pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><a name="_AEIOULastRenderedPageBreakAEIOU2"></a><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;"></font><font style="font-size:11pt;color:#000000;">Completed an oversubscribed and upsized $147 million initial public offering in February 2021 </font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.57%;white-space:nowrap">
<p style="text-align:left;margin-top:0pt;margin-bottom:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="top" style="width:3.57%;white-space:nowrap">
<p style="text-align:left;margin-top:0pt;margin-bottom:0pt;font-weight:normal;font-style:normal;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:11pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></font><font style="font-size:11pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="text-align:left;margin-top:0pt;margin-bottom:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;"></font><font style="font-size:11pt;color:#000000;">Cash and equivalents support operations into 2024</font></p></td></tr></table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><br /></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:7.5pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><img src="gmqzhpypc0jy000001.jpg" title="" alt="" style="width:213px;height:86px;"></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Terns also announced today that Erin Quirk, M.D., will assume the position of Head of Research &amp; Development, in addition to President and Chief Medical Officer, effective immediately. Weidong Zhong, Ph.D. will be leaving his position as Chief Scientific Officer and board member, effective as of July 2, 2021. In the interim, Dr. Zhong will continue to support Dr. Quirk to ensure a smooth transition.</p>
<p style="margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Mr. Sundaram continued, &#8220;On behalf of our board and&#160;our entire team, I would like to thank Weidong for all of the contributions he made in founding Terns but also in successfully building and advancing our diverse NASH pipeline. At the same time, we are pleased to expand Erin&#8217;s title in recognition of her ongoing role in leading our research, development and manufacturing teams, which she has done since 2020. With Erin&#8217;s leadership, I am confident that we are well positioned to continue to advance our current and future pipeline candidates through all stages of research and development.&#8221;</p>
<p style="Background-color:#FFFFFF;margin-bottom:12pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-weight:bold;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">First Quarter Financial Results</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.57%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="top" style="width:3.57%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></font><font style="font-size:10pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;"></font><font style="font-size:11pt;font-weight:bold;color:#000000;">Cash Position:</font><font style="font-size:11pt;color:#000000;">&#160;As of&#160;March 31, 2021, cash, cash equivalents and marketable securities were&#160;$195.6 million&#160;as compared with&#160;$74.9 million&#160;as of&#160;December 31, 2020. Based on its current operating plan, Terns expects these will be sufficient to fund its planned operating expenses into 2024.</font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.57%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="top" style="width:3.57%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></font><font style="font-size:10pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;"></font><font style="font-size:11pt;font-weight:bold;color:#000000;">Research and Development (R&amp;D) Expenses:</font><font style="font-size:11pt;color:#000000;">&#160;R&amp;D expenses were $8.7 million&#160;for the quarter ended&#160;March 31, 2021, as compared with $7.2 million&#160;for the quarter ended&#160;March 31, 2020. </font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.57%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="top" style="width:3.57%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></font><font style="font-size:10pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;"></font><font style="font-size:11pt;font-weight:bold;color:#000000;">General and Administrative (G&amp;A) Expenses:</font><font style="font-size:11pt;color:#000000;">&#160;G&amp;A expenses were $4.6 million&#160;for the quarter ended&#160;March 31, 2021, as compared with&#160;$2.2 million&#160;for the quarter ended&#160;March 31, 2020. </font></p></td></tr></table></div>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0"  style="border-collapse:collapse; width:100%;">
<tr>
<td valign="top" style="width:3.57%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></td>
<td valign="top" style="width:3.57%;white-space:nowrap">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"><font style="font-weight:normal;font-style:normal;text-decoration:none;Background-color:#auto;color:#auto;font-size:10pt;font-family:'Times New Roman';text-transform:none;font-variant: normal;letter-spacing:0pt;"></font><font style="font-size:10pt;font-family:'Times New Roman'">&#8226;</font></p></td>
<td valign="top">
<p style="text-align:left;margin-bottom:0pt;margin-top:0pt;font-weight:normal;font-style:normal;color:#auto;text-transform:none;font-variant: normal;letter-spacing:0pt;font-family:Times New Roman;font-size:12pt;"><font style="Background-color:#auto;text-decoration:none;"></font><font style="color:#000000;"></font><font style="font-size:11pt;font-weight:bold;color:#000000;">Net Loss:</font><font style="font-size:11pt;color:#000000;">&#160;Net loss was $13.3 million&#160;for the quarter ended&#160;March 31, 2021, as compared with $9.2 million&#160;for the quarter ended&#160;March 31, 2020.</font></p></td></tr></table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><br /></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><img src="gmqzhpypc0jy000001.jpg" title="" alt="" style="width:213px;height:86px;"></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="border-bottom:Solid 0.75pt;padding-bottom:1pt;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:11pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Terns Pharmaceuticals, Inc.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:11pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Condensed Consolidated Statements of Operations</p>
<p style="border-bottom:Solid 0.75pt;padding-bottom:1pt;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:11pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(Unaudited; in thousands except share and per share amounts)</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:63.44%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.82%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td colspan="6" valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:33.72%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Three Months Ended March&#160;31,</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:63.44%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.82%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.44%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.82%; border-top:solid 0.75pt #000000;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.44%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:63.44%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating expenses:</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.44%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.44%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:63.44%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Research and development</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.44%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8,735</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.44%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7,244</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:63.44%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">General and administrative</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.82%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.44%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,561</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.82%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.44%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,179</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:63.44%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total operating expenses</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.82%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.44%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">13,296</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.82%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.44%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9,423</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:63.44%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Loss from operations</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.44%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(13,296</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.44%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(9,423</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:63.44%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Interest income</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.44%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.44%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">50</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:63.44%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other (expense) income, net</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.82%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.44%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(13</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.82%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.44%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">167</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:63.44%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Loss before income tax expense</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.44%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(13,298</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.44%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(9,206</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:63.44%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:6.85pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Income tax expense</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.82%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.44%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(39</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.82%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.44%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:63.44%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.44%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(13,337</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.44%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(9,206</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:63.44%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss attributable to noncontrolling interest</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.82%; border-bottom:solid 0.75pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.44%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.82%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.44%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(205</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:63.44%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss attributable to common stockholders - basic and diluted</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.82%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.44%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(13,337</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.82%; border-bottom:double 2.5pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.44%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(9,001</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:63.44%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.44%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.82%;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.44%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:63.44%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net loss per share attributable to common stockholders, basic and diluted</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.82%; border-bottom:double 2.5pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.44%; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(0.88</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.82%; border-bottom:double 2.5pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.44%; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(41.69</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:63.44%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Weighted average common stock outstanding, basic and diluted</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.82%; border-bottom:double 2.5pt transparent;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.44%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15,160,046</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.82%; border-bottom:double 2.5pt transparent;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.44%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">215,890</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-weight:bold;;font-size:11pt;">&nbsp;</p>
<p style="border-bottom:Solid 0.75pt;padding-bottom:1pt;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:11pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Terns Pharmaceuticals, Inc.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:11pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Selected Balance Sheet Data</p>
<p style="border-bottom:Solid 0.75pt;padding-bottom:1pt;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:11pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">(Unaudited; in thousands)</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:11pt;">&nbsp;</p>
<div align="left">
<table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;">
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:60.66%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;;font-family:Times New Roman;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.96%; border-bottom:solid 0.75pt transparent;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.68%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">March&#160;31, 2021</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td colspan="2" valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:16.68%; border-bottom:solid 0.75pt #000000;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31, 2020</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:60.66%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cash, cash equivalents and marketable securities</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.68%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">195,581</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.68%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">74,854</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:60.66%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total assets</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.68%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">199,241</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.68%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">92,290</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:60.66%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total liabilities</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.68%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9,239</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.68%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">23,698</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:60.66%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Preferred stock</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.96%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.68%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.96%;">
<p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.68%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">186,033</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:60.66%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total stockholders&#8217; equity (deficit)</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.68%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">190,002</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.68%;white-space:nowrap;">
<p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(117,441</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td>
</tr>
<tr>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:60.66%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.68%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.96%;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.68%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
<td valign="bottom"  BGCOLOR="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;">
<p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td>
</tr>
</table></div>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><br /></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><img src="gmqzhpypc0jy000001.jpg" title="" alt="" style="width:213px;height:86px;"></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">About Terns Pharmaceuticals<font style="font-weight:normal;"><br />Terns Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, or NASH, and other chronic liver diseases. Terns&#8217; </font><font style="text-decoration:underline;font-weight:normal;">programs</font><font style="font-weight:normal;"> are based on clinically validated and complementary mechanisms of action to address the multiple hepatic disease processes of NASH in order to drive meaningful clinical benefits for patients.&nbsp;&nbsp;For more information, please visit </font><font style="text-decoration:underline;font-weight:normal;">www.ternspharma.com</font><font style="font-weight:normal;">. </font></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Cautionary Note Regarding Forward-Looking Statements</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">This press release contains forward-looking statements about Terns Pharmaceuticals, Inc. (the &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;us,&#8221; or &#8220;our&#8221;) within the meaning of the federal securities laws, including those related to the Company&#8217;s expectations of timing and potential results of the Company&#8217;s clinical trials and other development activities; the Company&#8217;s expectations regarding the profile of its product candidates, including tolerability, safety, metabolic stability and pharmacokinetic profile; the Company&#8217;s ability to continue to execute on its clinical strategy and plans; the potential utility and progress of the Company&#8217;s product candidates in NASH; and <font style="Background-color:#FFFFFF;">the sufficiency of our cash on hand to fund our operating expenses and capital expenditures</font>. All statements other than statements of historical facts contained in this press release, including statements regarding the Company&#8217;s strategy, future financial condition, future operations, future trial results, projected costs, prospects, plans, objectives of management and expected market growth, are forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as &#8220;aim,&#8221; &#8220;anticipate,&#8221; &#8220;assume,&#8221; &#8220;believe,&#8221; &#8220;contemplate,&#8221; &#8220;continue,&#8221; &#8220;could,&#8221; &#8220;design,&#8221; &#8220;due,&#8221; &#8220;estimate,&#8221; &#8220;expect,&#8221; &#8220;goal,&#8221; &#8220;intend,&#8221; &#8220;may,&#8221; &#8220;objective,&#8221; &#8220;plan,&#8221; &#8220;positioned,&#8221; &#8220;potential,&#8221; &#8220;predict,&#8221; &#8220;seek,&#8221; &#8220;should,&#8221; &#8220;target,&#8221; &#8220;will,&#8221; &#8220;would&#8221; and other similar expressions that are predictions of or indicate future events and future trends, or the negative of these terms or other comparable terminology. The Company has based these forward-looking statements largely on its current expectations, estimates, forecasts and projections about future events and financial trends that it believes may affect its financial condition, results of operations, business strategy and financial needs. In light of the significant uncertainties in these forward-looking statements, you should not rely upon forward-looking statements as predictions of future events. These statements are subject to risks and uncertainties that could cause the actual results and the implementation of the Company&#8217;s plans to vary materially, including the risks associated with the initiation, cost, timing, progress and results of the Company&#8217;s current and future research and development activities and preclinical studies and clinical trials. In particular, the impact of the COVID-19 pandemic on the Company&#8217;s ability to progress with its research, development, manufacturing and regulatory efforts, including the Company&#8217;s clinical trials for its product candidates, will depend on future developments that are highly uncertain and cannot be predicted with confidence at this time, such as the ultimate duration of the pandemic, travel restrictions, quarantines, social distancing and business closure requirements in&#160;the United States&#160;and in other countries, and the effectiveness of actions taken globally to contain and treat the disease. These risks are not exhaustive. For a detailed discussion of the risk factors that could affect the Company&#8217;s actual results, please refer to the risk factors identified in the Company&#8217;s SEC reports, including but not limited to its Annual Report on Form 10-K for the year ended December 31, 2020. Except as required by law, the Company undertakes no obligation to update publicly any forward-looking statements for any reason.</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><br /></p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<hr style="page-break-after:always;width:100%;">
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><img src="gmqzhpypc0jy000001.jpg" title="" alt="" style="width:213px;height:86px;"></p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Contacts for Terns</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Investors</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Justin Ng</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">investors@ternspharma.com</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-size:11pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Media</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cory Tromblee</p>
<p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">media@ternspharma.com</p>
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:12pt;">&nbsp;</p></body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>gmqzhpypc0jy000001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 gmqzhpypc0jy000001.jpg
M_]C_X  02D9)1@ ! 0$!+ $L  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" $/ IL# 2(  A$! Q$!_\0
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M\A5!8<[B  3^)YI]?F1^T!111GG'?T[T %%%% !1110 4444 %%%% !1110
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MBBBB[\_Z_P"&7W"LNR^X7)'3(HSD-DD@*3U(Z?Y_"DJ&[D$%G=3$X"0R=?\
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M\:*G@7]AC5$NB8S!\,U\P-@%9)K5'V\]]J=.O45_&;>,INKAPV8VDW!N>FT
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M&$KU:4[)\LX4W*+L]'9I:/1['XF#_@[#\4>7'GX&VGGMM5A_:-IY0E(P</\
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M_2:6O\B;XH_\E'^)'_8\>,/_ $^ZA7Z?X<;YI_AH?^E,_$_&'^%DW_7W$_\
MI%(_L=_X-4_ _@WQ%X!^.5YX@\.:3K5XNOPK#-J5C;WGE(=+T@,J>>CXR"QX
M P6XYYK^OG_A4/PN_P"A \)_^"2Q_P#C-?R6_P#!IYG_ (5U\<3CC_A((/\
MTV:17]C%?)\5RDL_S'WI?QEI=V7N15D?>\"0A_JGDON1_P!UO\*_GEY'G/\
MPJ'X7?\ 0@>$_P#P26/_ ,9H_P"%0_"[_H0/"?\ X)+'_P",UZ-17SO//^:7
MWO\ S/KN2'\D?_ 5_EY+[CS@_"#X6D$'X?\ A/!_Z@EC_P#&J['1M!T7P[:+
M8:%I=CI-DARMK86T=M #ZB.)57/X5K44G*3T;;7FVP48IW48I[744G^""OX6
M/^#KK_DHOP=^J_\ I"]?W3U_"Q_P==?\E%^#OU7_ -(7KZ;@[_DH,#ZU/_3<
MCXSQ"_Y)+-/\%/\ ].1/YG_V0;.TU']JKX!V.H0)=6-SX_L([JVD4-'-&(9V
MV.IX9<J#@\9'-?ZQWPW^$WPP?X?>#5'@+PLR+X?TYEWZ+8E\O;1EBS>3N8DC
MG)/M7^3S^QM_R=I^S[_V4&Q_])[BO]<;X9_\D^\'?]B]IG_I,E?0>(DI+&X&
MS:_V5[-K_E[5/D_"&,995F7-%/\ X4);I/\ YA\+W*7_  J'X7'KX \)_P#@
MEL?_ (U1_P *A^%W_0@>$_\ P26/_P 9KT:BOSKGG_-+[W_F?KW)#^2'_@*_
MR/(]<^ OP<\1:9=:1JOPY\*7%C>1/#/$-'LT+1R*58!EBR,AC7\0?_!P-_P2
M$\!?LVVEK^U%^SMH<>A>%-8U/[/XT\(Z;;A;2TDN)7EN=86.)$1)//F$DTJ
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ME<U?MF8?\D3+_L78;_TY1/YLRO\ Y.@O^QIB_P#U%F?Z,%%%%?B1_2@4444
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M/$5?;3^M4:M62ERTX/E=.O1LG&G'=/6^NNG]^W_$4G^RI_T*/BW_ ,$U]_\
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M+VT4>/-!\$Z9K/@35XU'VJSURWT>V>W*R8#%/-7>T9S'*C2PRJ\<C*?\U?\
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M?^P)9_\ I,M?H7B'_P BS!_]AG_N*9^0>#W_ ".<R_[%M/\ ]/H_9.OYWO\
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M*W?\I _CE_U^6G_H=Q7Z*?\ !LI_R?#K/_8'M/\ TKFK]LS#_DB9?]B[#?\
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M>'_%6FLKV'B#2;+5;5D;<IBO(5E7:PSD#<1U/3K71U^.7_!#S]JY/VJ?V'?
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MQQC^*,?B<+B\+A\/"AAXU5*BY-RDVEROF7G^/W?NS7\+'_!UU_R47X._5?\
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M:9_,O^R7_P G1_ O_LH?A?\ ]/-K7^O)X!_Y$?P=_P!BQH7_ *;+:O\ (/\
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MMZ-I2;LVM['/A\OP.#DY87"8?#RDDI.A2A3<DME+D2O;I>]M;;L*^$_VJ?\
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MT?9DR+MW 9 8CA6Q]2^$O$VF^,_#6B^*M'9GTO7K"#4K%W&&:WN%W1EAV)%
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M7BUO6(8KK:F_;;PXN)-PP<*ZIL+'@;L]<$?I9_P6:_Y+/X9_Z]I__10KK/\
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M]PSA03M6)6)R"".I&* ///!_[=_C*/X0:%CX#^)76W\&65FNV&79(D.D) )
MH.TJR)NQCD')')KF/^"1.I?V[X<^+?B)M/&ESZ_X]UW5;G3FC"2V4MQ>.6@E
M'#"1.C!@3UR:_43P?X>LX/A1X>LY]"TZ.\B\#6%O-:&Q@^6ZCT5(WB8&/=N\
MT$-SG<3C'%?FS^P#X>\<_"3PM^TAXD\3>$KK3VC\=>*-6T+3Q&R_VE:-/++:
M?9X]HVK+L4 +P<@@8(H Y_\ :@B\/_M9_M@>&_V8-;UFR3P!X/\ #G_"7^(E
MEO8X$DU.$,R6@+2*#(65@4X9B$!P#5S]@/Q+:?!;X[?&C]DV6^M[C2K'6I?$
M/@#R+Q;J)-%,9>:W0J6"^5))C:#C;(GX>2?LQ?L.^(OCOXC^)/[0OQDN?$?@
MCQ9XJ\7:BWA_3[2_N[2\L_#\@58(GDB*ML9(HRRGC)XY!PSXM_L@>-?V3/CA
M\,/C[\%FUOQBE]KEIH'C:VNKF>]NQI=]-;I=WS22*\NV&*-25#88*<\$F@#J
M?^"J.O6'A'XO?LY^*-2TL:Y9:=K*^?I7D"Y:X0W&['D%6\P J&VXP60'&0,7
MOC%^W/\ !WXA^#[[X*>'_A5#?_$7QKHZZ-H7A[5="BTI9;F[M-@DMKB>VC&V
MWS]Z-FP,X!P"._\ VY_ _C'Q[\;?V8O$7A_PI-KVBV%S;WNN9B\VWLS-=V[;
M;B,KC"033/W.Z( @!B1ZO^W'^R>OQ3^'6E?$'X6:/8:)\:OAK#;ZWX.OM.M(
M;22>:T1+A["=H(T>2.4Q^4RONW!LD%D4T <]\"/@KXP^ /[!VO\ @GQW*SZZ
M=*UC4I[*25KA=/CU ><EE%))RT4 D*(.,+& ,#%?FY^QKX93]GOXB^ OBY!<
M&#1OBUXJO_#%_*6"6UM#&UQ<1*S$[(T\UI@!POS8Z#%?JC\/?B-\3/C-^QWX
MH7QUX3O='^)^G:#?Z)J>BS1R++>WEC"(%NHLDEENBA<,K/\ >^^_WC\/:I\"
M/B9XB_X)PRVL/AN^TWXH^$-<U#6-$TU=\=^)TNYA%)#( 7C:1&C.5/R[N,@
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M._[%_P"T7\6_C/HWPB/QP^'OQ1NX]1N;A2+O5/#Q@.UXK2.96<1B(^8(X6#
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
2*** "BBB@ HHHH **** /__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>tern-20210513.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN ActiveDisclosure(SM) XBRL Schema Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date      : 2021-05-07T10:07:37.9821778+00:00 -->
<!-- Version            : 5.0.1.615 -->
<!-- Package ID         : 16ad461f404a4152b2b59769edde4f81 -->
<!-- Copyright (c) 2021 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:us-types="http://fasb.org/us-types/2020-01-31" xmlns:stpr="http://xbrl.sec.gov/stpr/2018-01-31" xmlns:srt-types="http://fasb.org/srt-types/2020-01-31" xmlns:sic="http://xbrl.sec.gov/sic/2020-01-31" xmlns:tern="http://www.ternspharma.com/20210513" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:srt="http://fasb.org/srt/2020-01-31" xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31" xmlns:naics="http://xbrl.sec.gov/naics/2017-01-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:country="http://xbrl.sec.gov/country/2020-01-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:currency="http://xbrl.sec.gov/currency/2020-01-31" xmlns:exch="http://xbrl.sec.gov/exch/2020-01-31" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.ternspharma.com/20210513" xmlns:xsd="http://www.w3.org/2001/XMLSchema">
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance" />
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase" />
  <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd" namespace="http://xbrl.sec.gov/country/2020-01-31" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd" namespace="http://xbrl.sec.gov/currency/2020-01-31" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd" namespace="http://xbrl.sec.gov/dei/2020-01-31" />
  <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/non-numeric" />
  <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/numeric" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/exch/2020/exch-2020-01-31.xsd" namespace="http://xbrl.sec.gov/exch/2020-01-31" />
  <xsd:import schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd" namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" />
  <xsd:import schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd" namespace="http://www.xbrl.org/2009/role/negated" />
  <xsd:import schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd" namespace="http://www.xbrl.org/2009/role/net" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd" namespace="http://xbrl.sec.gov/naics/2017-01-31" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/sic/2020/sic-2020-01-31.xsd" namespace="http://xbrl.sec.gov/sic/2020-01-31" />
  <xsd:import schemaLocation="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd" namespace="http://fasb.org/srt/2020-01-31" />
  <xsd:import schemaLocation="http://xbrl.fasb.org/srt/2020/elts/srt-roles-2020-01-31.xsd" namespace="http://fasb.org/srt-roles/2020-01-31" />
  <xsd:import schemaLocation="http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd" namespace="http://fasb.org/srt-types/2020-01-31" />
  <xsd:import schemaLocation="https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd" namespace="http://xbrl.sec.gov/stpr/2018-01-31" />
  <xsd:import schemaLocation="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd" namespace="http://fasb.org/us-gaap/2020-01-31" />
  <xsd:import schemaLocation="http://xbrl.fasb.org/us-gaap/2020/elts/us-roles-2020-01-31.xsd" namespace="http://fasb.org/us-roles/2020-01-31" />
  <xsd:import schemaLocation="http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd" namespace="http://fasb.org/us-types/2020-01-31" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:roleType id="TemplateLink" roleURI="http://www.ternspharma.com/20210513/role/TemplateLink" xmlns:link="http://www.xbrl.org/2003/linkbase">
        <link:definition>00000 - Document - Template Link</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="tern-20210513_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="tern-20210513_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple" />
      <link:roleType roleURI="http://www.ternspharma.com/20210513/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>tern-20210513_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN ActiveDisclosure(SM) XBRL Linkbase Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date      : 2021-05-07T10:07:37.9821778+00:00 -->
<!-- Version            : 5.0.1.615 -->
<!-- Package ID         : 16ad461f404a4152b2b59769edde4f81 -->
<!-- Copyright (c) 2021 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" xlink:type="simple" />
  <link:roleRef roleURI="http://fasb.org/us-gaap/role/label/axisDefault" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-roles-2020-01-31.xsd#axisDefault" xlink:type="simple" />
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityExTransitionPeriod" xlink:type="locator" xlink:label="dei_EntityExTransitionPeriod" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityExTransitionPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Ex Transition Period</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityExTransitionPeriod" xlink:to="dei_EntityExTransitionPeriod_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityExTransitionPeriod_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Ex Transition Period</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation, State or Country Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address Address Line1</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine2" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line Two</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address Address Line2</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address City Or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address State Or Province</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Written Communications</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Soliciting Material</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre-commencement Tender Offer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre-commencement Issuer Tender Offer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Issuer Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Title of each class</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security12b Title</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>tern-20210513_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN ActiveDisclosure(SM) XBRL Linkbase Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date      : 2021-05-07T10:07:37.9821778+00:00 -->
<!-- Version            : 5.0.1.615 -->
<!-- Package ID         : 16ad461f404a4152b2b59769edde4f81 -->
<!-- Copyright (c) 2021 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.ternspharma.com/20210513/role/TemplateLink" xlink:href="tern-20210513.xsd#TemplateLink" xlink:type="simple" />
  <link:roleRef roleURI="http://www.ternspharma.com/20210513/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="tern-20210513.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://www.ternspharma.com/20210513/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine2" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine2" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityExTransitionPeriod" xlink:type="locator" xlink:label="dei_EntityExTransitionPeriod" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="10010.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="10030.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="10050.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="10070.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="10090.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="10110.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityExTransitionPeriod" order="10130.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="10150.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="10170.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="10190.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="10210.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine2" order="10230.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="10250.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="10270.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="10290.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="10310.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="10330.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications" order="10350.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial" order="10370.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer" order="10390.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="10410.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="10430.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="10450.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="10470.00" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>tern-8k_20210513_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="tern-20210513.xsd" xlink:type="simple"/>
    <context id="C_0001831363_20210513_20210513">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001831363</identifier>
        </entity>
        <period>
            <startDate>2021-05-13</startDate>
            <endDate>2021-05-13</endDate>
        </period>
    </context>
    <dei:AmendmentFlag contextRef="C_0001831363_20210513_20210513" id="F_000001">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="C_0001831363_20210513_20210513" id="F_000004">0001831363</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="C_0001831363_20210513_20210513" id="F_000000">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="C_0001831363_20210513_20210513" id="F_000002">2021-05-13</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="C_0001831363_20210513_20210513" id="F_000003">Terns Pharmaceuticals, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="C_0001831363_20210513_20210513" id="F_000008">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="C_0001831363_20210513_20210513" id="F_000007">001-39926</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="C_0001831363_20210513_20210513" id="F_000009">98-1448275</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="C_0001831363_20210513_20210513" id="F_000010">1065 East Hillsdale Blvd</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="C_0001831363_20210513_20210513" id="F_000011">Suite 100</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="C_0001831363_20210513_20210513" id="F_000012">Foster City</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="C_0001831363_20210513_20210513" id="F_000013">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="C_0001831363_20210513_20210513" id="F_000014">94404</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="C_0001831363_20210513_20210513" id="F_000015">650</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="C_0001831363_20210513_20210513" id="F_000016">525-5535</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="C_0001831363_20210513_20210513" id="F_000017">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="C_0001831363_20210513_20210513" id="F_000018">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="C_0001831363_20210513_20210513" id="F_000019">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="C_0001831363_20210513_20210513" id="F_000020">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="C_0001831363_20210513_20210513" id="F_000021">Common Stock, $0.0001 par value per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="C_0001831363_20210513_20210513" id="F_000022">TERN</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="C_0001831363_20210513_20210513" id="F_000023">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="C_0001831363_20210513_20210513" id="F_000005">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod contextRef="C_0001831363_20210513_20210513" id="F_000006">false</dei:EntityExTransitionPeriod>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140658089538408">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>May 13, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">May 13,  2021<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Terns Pharmaceuticals, Inc.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001831363<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Entity Ex Transition Period</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-39926<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">98-1448275<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">1065 East Hillsdale Blvd<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 100<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Foster City<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">94404<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">650<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">525-5535<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of each class</a></td>
<td class="text">Common Stock, $0.0001 par value per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">TERN<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>9
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0    ( #2"K5('04UB@0   +$    0    9&]C4')O<',O87!P+GAM
M;$V./0L",1!$_\IQO;=!P4)B0-!2L+(/>QLOD&1#LD)^OCG!CVX>;QA&WPIG
M*N*I#BV&5(_C(I(/ !47BK9.7:=N')=HI6-Y #OGD<Z,STA)8*O4'J@)I9GF
M3?X.CD:?<@X>K7A.YNJQ<&4GPZ4A!0W_<FW>J=0U[R;UEA_6\#MI7E!+ P04
M    "  T@JU2G(%$0>X    K @  $0   &1O8U!R;W!S+V-O<F4N>&ULS9+/
M2L0P$(=?17)OIVFQ0NCFLN))07!!\1:2V=U@\X=DI-VWMZV[740?P&-F?OGF
M&YA.1Z%#PN<4(B:RF&]&U_LL=-RP(U$4 %D?T:E<3@D_-?<A.473,QT@*OVA
M#@AU5;7@D)11I& &%G$E,MD9+71"12&=\4:O^/B9^@5F-&"/#CUEX"4')N>)
M\33V'5P!,XPPN?Q=0+,2E^J?V*4#[)P<LUU3PS"40[/DIATXO#T]OBSK%M9G
M4E[C]"M;0:>(&W:9_-IL[W</3-95S8OJMN#-CK>"WXFF?9]=?_A=A5TP=F__
ML?%%4';PZR[D%U!+ P04    "  T@JU2F5R<(Q &  "<)P  $P   'AL+W1H
M96UE+W1H96UE,2YX;6SM6EMSVC@4?N^OT'AG]FT+QC:!MK03<VEVV[29A.U.
M'X416(UL>621A'^_1S80RY8-[9)-NIL\!"SI^\Y%1^?H.'GS[BYBZ(:(E/)X
M8-DOV]:[MR_>X%<R)!%!,!FGK_# "J5,7K5::0##.'W)$Q+#W(*+"$MX%,O6
M7.!;&B\CUNJTV]U6A&ELH1A'9&!]7BQH0-!445IO7R"TY1\S^!7+5(UEHP$3
M5T$FN8BT\OELQ?S:WCYES^DZ'3*!;C ;6"!_SF^GY$Y:B.%4PL3 :F<_5FO'
MT=)(@(+)?90%NDGVH],5"#(-.SJ=6,YV?/;$[9^,RMIT-&T:X./Q>#BVR]*+
M<!P$X%&[GL*=]&R_I$$)M*-IT&38]MJND::JC5-/T_=]W^N;:)P*C5M/TVMW
MW=..B<:MT'@-OO%/A\.NB<:KT'3K:28G_:YKI.D6:$)&X^MZ$A6UY4#3( !8
M<';6S-(#EEXI^G64&MD=N]U!7/!8[CF)$?[&Q036:=(9EC1&<IV0!0X -\31
M3%!\KT&VBN#"DM)<D-;/*;50&@B:R('U1X(AQ=RO_?67N\FD,WJ=?3K.:Y1_
M::L!I^V[F\^3_'/HY)^GD]=-0LYPO"P)\?LC6V&')VX[$W(Z'&="?,_V]I&E
M)3+/[_D*ZTX\9Q]6EK!=S\_DGHQR([O=]EA]]D]';B/7J<"S(M>41B1%G\@M
MNN01.+5)#3(3/PB=AIAJ4!P"I DQEJ&&^+3&K!'@$WVWO@C(WXV(]ZMOFCU7
MH5A)VH3X$$8:XIQSYG/1;/L'I4;1]E6\W*.76!4!EQC?-*HU+,76>)7 \:V<
M/!T3$LV4"P9!AI<D)A*I.7Y-2!/^*Z7:_IS30/"4+R3Z2I&/:;,CIW0FS>@S
M&L%&KQMUAVC2/'K^!?F<-0H<D1L= F<;LT8AA&F[\!ZO)(Z:K<(1*T(^8ADV
M&G*U%H&V<:F$8%H2QM%X3M*T$?Q9K#63/F#([,V1=<[6D0X1DEXW0CYBSHN0
M$;\>ACA*FNVB<5@$_9Y>PTG!Z(++9OVX?H;5,VPLCO='U!=*Y \FIS_I,C0'
MHYI9";V$5FJ?JH<T/J@>,@H%\;D>/N5Z> HWEL:\4*Z">P'_T=HWPJOX@L Y
M?RY]SZ7ON?0]H=*W-R-]9\'3BUO>1FY;Q/NN,=K7-"XH8U=RS<C'5*^3*=@Y
MG\#L_6@^GO'M^MDDA*^:62TC%I!+@;-!)+C\B\KP*L0)Z&1;)0G+5--E-XH2
MGD(;;NE3]4J5U^6ON2BX/%ODZ:^A=#XLS_D\7^>TS0LS0[=R2^JVE+ZU)CA*
M]+',<$X>RPP[9SR2';9WH!TU^_9==N0CI3!3ET.X&D*^ VVZG=PZ.)Z8D;D*
MTU*0;\/YZ<5X&N(YV02Y?9A7;>?8T='[Y\%1L*/O/)8=QXCRHB'NH8:8S\-#
MAWE[7YAGE<90-!1M;*PD+$:W8+C7\2P4X&1@+: '@Z]1 O)256 Q6\8#*Y"B
M?$R,1>APYY=<7^/1DN/;IF6U;J\I=QEM(E(YPFF8$V>KRMYEL<%5'<]56_*P
MOFH]M!5.S_Y9K<B?#!%.%@L22&.4%Z9*HO,94[[G*TG$53B_13.V$I<8O./F
MQW%.4[@2=K8/ C*YNSFI>F4Q9Z;RWRT,"2Q;B%D2XDU=[=7GFYRN>B)V^I=W
MP6#R_7#)1P_E.^=?]%U#KG[VW>/Z;I,[2$R<><41 71% B.5' 86%S+D4.Z2
MD 83 <V4R43P H)DIAR F/H+O?(,N2D5SJT^.7]%+(.&3E[2)1(4BK ,!2$7
M<N/O[Y-J=XS7^BR!;814,F35%\I#B<$],W)#V%0E\Z[:)@N%V^)4S;L:OB9@
M2\-Z;ITM)__;7M0]M!<]1O.CF> >LX=SFWJXPD6L_UC6'ODRWSEPVSK> U[F
M$RQ#I'[!?8J*@!&K8KZZKT_Y)9P[M'OQ@2";_-;;I/;=X Q\U*M:I60K$3]+
M!WP?D@9CC%OT-%^/%&*MIK&MQMHQ#'F 6/,,H68XWX=%FAHSU8NL.8T*;T'5
M0.4_V]0-:/8--!R1!5XQF;8VH^1."CS<_N\-L,+$CN'MB[\!4$L#!!0    (
M #2"K5)_QON]<@0  (P1   8    >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL
MC9A=<^(V%(:OM[]"P_0RB6WQ$=@!9@@AW<QNLC30[DP[O1"V $UDRY5D/OY]
MCXQCT]8<<P.V\7G]2.?H/3+#O=+O9LNY)8=8)F;4VEJ;?O8\$VYYS,R=2GD"
MOZR5CIF%4[WQ3*HYB_*@6'K4]WM>S$32&@_S:W,]'JK,2I'PN28FBV.FCP]<
MJOVH%;0^+KR)S=:Z"]YXF+(-7W#[6SK7<.:5*I&(>6*$2HCFZU%K$GQ^H#T7
MD-_QN^![<W9,W%!62KV[D^=HU/(=$9<\M$Z"P=>.3[F43@DX_BY$6^4S7>#Y
M\8?Z4SYX&,R*&3Y5\H>([';4ZK=(Q-<LD_9-[;_P8D!=IQ<J:?)/LC_=V^FT
M2)@9J^(B& ABD9R^V:&8B/, >B& %@$TYSX]**=\9):-AUKMB79W@YH[R(>:
M1P.<2%Q6%E;#KP+B[/A1A1E,LB4LB<@LL<(>R7-RRC;,VM"S\!!WJQ<6@@\G
M07I!\(4=2="^(=2GP;^C/4 K^6C)1W.Y]@6YJ=IQ3?Z<K(S5D,&_$,EV*=G.
M)3M-0UX>4UXW0#R\?_L5@>B4$!U490($44[Q)-FFC@*/7S-I.,+1+3FZUTW&
MG&NA7 E$! JI=EYPI2+Q/WWZU)#Z7HG60P6+:GSC&^&2#XRO+*X%PW667">&
MS+<,:CKDF14AS-T-5'EXAU#>EY3WUU!.80XUDZ :\0/YRH]UG+B2[_M!OQVT
M>VT$JU]B]:_!FL5<;T2R(;] O-V2J8I3EM3"X7I69UBY#4JLP558![*$C!J1
M._.I].J8<+&F-1#XE0GZUV ]"<G):Q:ON*XU/EP$TG?;'@QH#T,Z\^7@&B2H
M4J53I7,WOB$+"VN3* V)S*#@H.Y45+LD&M0?9QAD9<X!O09RR0[D.8(5(-:P
MN/*<(K.(2P[ZMT&GTZ?W78RP\OH =^N"<!)%FAM8]<4!^0;WD>])_=SADH'?
MZY(9,Y9\$5*:B$'1/,A=A/%6;2' ?1WE7>Y5+2\NN<@$U$S@^QA@U2\"W.;_
M"SAU9U"02[6OWRW@<D_*6&CP3@7#JWI&<%73*/'*!3/7:B>2L#[AN.9T@J%5
MC2*XJE.4:',8.G2,/T1Z>17CBH-.Q^]@;%6W"'![S[,X@6W]911<H-=%RZOJ
M#P'NZ=\4=&=HUBI!G1@7Z=+N;;?;QAR$5KV!XK;^0PMK>>):9YPEA;^9.JH&
MH:9V1:O>0''W7B@I0NB=T-=?H+RU8+*6!U=IY#G;H^.>/=?\-H3IX;"^3CMK
MV-S"JOZ^7M?GKT&OD:RR?XI[]?_(GHW)@*P1$)=M!*S\GN+FO!06VH=:$\["
M+0DE,_6EA:NXVH2FN[ J?+\A/_MW;B])4J;)CLF,DQ3&:F #C#)7+8#BG@U;
MM\C5WN(8KU1]Y34(S-Y>,9+*[2GNS L>9OJTH0RW+-GPBZ\(#4*OD\7CY-<Z
M)N_LW=K]3_'"W(;:$,G7H.3?W<-0]>G5_W1B59J_;J^4A9?W_'#+&52;NP%^
M7RME/T[<&WSY!\SX'U!+ P04    "  T@JU2GZ ;\+$"  #B#   #0   'AL
M+W-T>6QE<RYX;6S=5VUKVS 0_BM"/V!N8FKBD1BV0&&PC4+S85^56'8$>O%D
MN7/ZZZ>S;"=I=67=A['-H<G=/;J[1W<GF:Y;=Y+\X<BY([V2NMW0HW/-^R1I
M#T>N6/O.-%Q[I#)6,>=56R=M8SDK6W!2,EG>W&2)8D+38JT[=:=<2PZFTVY#
M;VA2K"NCSY:4!H-?RA0GCTQNZ)9)L;=B6,N4D*=@7H+A8*2QQ'DJ?$,78&F?
M KP(&K <XRBAC05C$C*$[_VX_!DP::U7A90SP24-AF+=,.>XU7=>&18/QA<0
M&>7=J?$,:\M.B^4M/3L,/S[)WMB2VSG-@DZF8BUY!72LJ(_PZTR3 .B<45XH
M!:N-9@.'R6,4?-@#E_(!6OBMNHK=5R3TXE,);2"PU4GTA$8QA D*Q+^,%F)?
MA+W]K;"D$8_&?>S\;O2@?^^,X_>65Z(?]+Z:\V/1%WATUC3R]$&*6BL>]O[+
M"8LUF_S(T5CQY+/!I!R\@5M*'KEUXG!I^6%9L^.]FZ:IKW#.RW^0\Y^M<\TU
MMTQ>DO:C_S=7^2V,D_'T7!S1JP,Z6PE<A!OZ%>Y7>>9 ]IV03NA1.XJRY/K%
M.?7A'=O["_PJOE]?\HIUTNUF<$//\A=>BD[E\ZI[J,NXZBQ_AOMHD<VWL,\E
M=,E[7FY'U=;[021>\%G'!QR>(W?#$T<PGX#%$<"P/!@#S"=X87G^I_VLT/T$
M#..VBB(KU&>%^@2O&+(=/EB>N$_NG_A.\SQ-LPRKZ'8;9;#%ZI9E\!>/AG$#
M#RP/9'I;K?%NXQ/R^AQ@/7UM0K"=XI.([12O-2#QNH%'GL>[C>4!#ZP+V.Q
M_G@>F*FX3YI"5S%NV G&D3S'$)C%^(QF&5*=##[Q_F"G)$WS/(X %F>0IA@"
MIQ%', ;  4/2='@//GL?)=-[*CG_5U/\!%!+ P04    "  T@JU2EXJ[',
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MK5(<.&7J/P$  #P"   /    >&PO=V]R:V)O;VLN>&ULC5'+;L) #/R5U7Y
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M%0:P;W(@"2[)E1M27>EYIK=WDWM)J'7N0;#W\!J-'<V/'[?\ 5!+ P04
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MUDX:?^:+X3]>?P%02P$"% ,4    "  T@JU2!T%-8H$   "Q    $
M        @ $     9&]C4')O<',O87!P+GAM;%!+ 0(4 Q0    ( #2"K5*<
M@41![@   "L"   1              "  :\   !D;V-0<F]P<R]C;W)E+GAM
M;%!+ 0(4 Q0    ( #2"K5*97)PC$ 8  )PG   3              "  <P!
M  !X;"]T:&5M92]T:&5M93$N>&UL4$L! A0#%     @ -(*M4G_&^[UR!
MC!$  !@              ("!#0@  'AL+W=O<FMS:&5E=',O<VAE970Q+GAM
M;%!+ 0(4 Q0    ( #2"K5*?H!OPL0(  .(,   -              "  ;4,
M  !X;"]S='EL97,N>&UL4$L! A0#%     @ -(*M4I>*NQS     $P(   L
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64$L%!@     )  D /@(  !44      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.21.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>96</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="tern-8k_20210513.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.ternspharma.com/20210513/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="tern-8k_20210513.htm">tern-8k_20210513.htm</File>
    <File>tern-20210513.xsd</File>
    <File>tern-20210513_lab.xml</File>
    <File>tern-20210513_pre.xml</File>
    <File>tern-ex991_6.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2020-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>14
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "tern-8k_20210513.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "contextCount": 1,
   "dts": {
    "definitionLink": {
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-eedm-def-2020-01-31.xml",
      "http://xbrl.fasb.org/srt/2020/elts/srt-eedm1-def-2020-01-31.xml"
     ]
    },
    "inline": {
     "local": [
      "tern-8k_20210513.htm"
     ]
    },
    "labelLink": {
     "local": [
      "tern-20210513_lab.xml"
     ],
     "remote": [
      "https://xbrl.sec.gov/dei/2020/dei-doc-2020-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "tern-20210513_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "https://xbrl.sec.gov/dei/2020/dei-ref-2020-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "tern-20210513.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "https://xbrl.sec.gov/currency/2020/currency-2020-01-31.xsd",
      "https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "https://xbrl.sec.gov/exch/2020/exch-2020-01-31.xsd",
      "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://xbrl.sec.gov/naics/2017/naics-2017-01-31.xsd",
      "https://xbrl.sec.gov/sic/2020/sic-2020-01-31.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-roles-2020-01-31.xsd",
      "https://xbrl.sec.gov/stpr/2018/stpr-2018-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-roles-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd"
     ]
    }
   },
   "elementCount": 25,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2020-01-31": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 96,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "tern",
   "nsuri": "http://www.ternspharma.com/20210513",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "p",
       "body",
       "html"
      ],
      "baseRef": "tern-8k_20210513.htm",
      "contextRef": "C_0001831363_20210513_20210513",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "100000 - Document - Document and Entity Information",
     "role": "http://www.ternspharma.com/20210513/taxonomy/role/DocumentDocumentAndEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "p",
       "body",
       "html"
      ],
      "baseRef": "tern-8k_20210513.htm",
      "contextRef": "C_0001831363_20210513_20210513",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.ternspharma.com/20210513/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.ternspharma.com/20210513/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.ternspharma.com/20210513/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.ternspharma.com/20210513/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address Address Line1",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.ternspharma.com/20210513/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address Address Line2",
        "terseLabel": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.ternspharma.com/20210513/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address City Or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.ternspharma.com/20210513/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.ternspharma.com/20210513/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address State Or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.ternspharma.com/20210513/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.ternspharma.com/20210513/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.ternspharma.com/20210513/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Entity Ex Transition Period",
        "terseLabel": "Entity Ex Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.ternspharma.com/20210513/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.ternspharma.com/20210513/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation State Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.ternspharma.com/20210513/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.ternspharma.com/20210513/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.ternspharma.com/20210513/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.ternspharma.com/20210513/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre Commencement Issuer Tender Offer",
        "terseLabel": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.ternspharma.com/20210513/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre Commencement Tender Offer",
        "terseLabel": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.ternspharma.com/20210513/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Security12b Title",
        "terseLabel": "Title of each class"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.ternspharma.com/20210513/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.ternspharma.com/20210513/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.ternspharma.com/20210513/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.ternspharma.com/20210513/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://www.ternspharma.com/20210513/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  },
  "r7": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>15
<FILENAME>0001564590-21-027565-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001564590-21-027565-xbrl.zip
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M)W^Q&[/..19*B7%037K#<DH208H*VD)PB^RXW&;7!F0O3M9/4SP'YF4YVHP
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M0BOW*V^&^90\X8 <,L)T0@N9G&1X3%C;R/>U_WN0(XFU_ [7P5BP<]&]<BH
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M(TCIY$B&U$\9<=*7MY.,C5&;4 ".>$@]P@;,B?!$#KP&#<?D'AJ\7H0N>P(
M$H00PS?8]4=B]N?0WZ^?:K9U<"B)8AX+>]"&^%K%9U%!!:- )Y<UR,YLBE>S
M%$?>/H5FR]-XOSJE9G;G\-E^=M2O@4.]6YS%*AOCJETM5JOEW&WQ-GSWBN$[
M,_R.'-OYW?Y(O#1[S'G0>3TT!'T)>@7]!)U@0#K,"YX(CY-^+J ^J15_)UWN
MH31Q":*E&,S Q9PAR?N1IZC/@DAZ0R+!SI+=H6Z9- @ZP&NQ^97D$64"SQ'T
M(PCUAVE9-_!@<&R'.ISC#DTVR&;1,&ONEHUR^9<EJ'K'[@-&OEV2NV$?E.:K
M4W6VJAGS#?]3< 5$Q&UPY"?6L?R^A;<3!%Z' O44\!#BMGY0J1Q.+W=3"]T,
M?B^<)$ "5%DH29A)66M%8&56[&K"2,A!F=0NS.C:L0Y(\Z)%[+)I0,69Z^$'
MI?I8/ LUMP.H\>^O0-:A$V_32/X,(>DG($[3VZK0HF5G2#Z6PC<B>,4TXIH_
M&\W'7.^W@J&4X[$@G>",FEO<=+M+FA<_@/8 :=')@/JBW%L5MVCO='87XX2X
M[D_&"[8YAQ<NI8R8^% <46;%"A[/7X0CDKJK<T2>63SCR-0[LHP_4^?A7@2
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MOGA!!V^)91YS%+FBXH&I!0XRS$Q/G$L;[9K:G(R#2]]%USTCG2%Q=/8!P/H
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M JRU71@2I!(Z)\ C_@TT&+)<@RNN \Z]J(#.]COB5\3$I*_6,$5<@T-@4 !
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M(NX5!Z-YB]\3].OF?B-H-%H.*<7[A&> U1&WMW;/ '-^44JSN1ML^?7L<U/
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MH)L&PP!9\+ZR;27@*L*^YRS4QNT-'&F>&@H!Q,O![#+-H1*0%V"9JNH>+V,
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M-$PV%'% DRN"'HW*C&6 .P&P%^ )024D*&W0J)-_?CRN-??A,HC54XB&[(C
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M_P]02P$"% ,4    "  T@JU2)'7,DK $  #)%@  $0              @ $
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B+65X.3DQ7S8N:'1M4$L%!@     %  4 10$  /X_      $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
